EPISODE · May 15, 2026 · 51 MIN
PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida
Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.CME information and select publications here.
NOW PLAYING
PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida
No transcript for this episode yet
Similar Episodes
Apr 10, 2026 ·42m
Mar 28, 2026 ·31m
Mar 13, 2026 ·30m
Mar 1, 2026 ·27m
Feb 28, 2026 ·35m